Established in 2015, the Center for Vaccines and Immunology (CVI) provides an environment for world-class research and training in immunology. The CVI is advancing fundamental and translational immunological knowledge to develop new vaccines and therapies for infectious diseases and other immunity-related diseases and syndromes.
Infographic with Center for Vaccines & Immunology (CVI) surrounded by 5 main goals of center activity
Latest News
UGA vaccine protects against multiple fungal infections
A vaccine created by University of Georgia researchers to battle multiple life-threatening fungal infections is also effective against Candida auris in mice, according to a new study from researchers in the UGA Center for Vaccines and Immunology.
Vaccine elicitation of HIV broadly neutralizing antibodies from genome-edited B cells in non-human primates and derived lymphoid organoids
Gene Ther. April 2026
Cage-Side Blood Collections from the Ear Can Be Used for Hematological Evaluations in Japanese Macaques (Macaca fuscata)
J Am Assoc Lab Anim Sci. March 2026
Receptor-binding specificity and antigenic properties of a genotype D1.1 A (H5N1) influenza virus isolated from a human
Emerg Microbes Infect. March 2026
Assessment of immunogenicity and protection induced by COBRA HA vaccines formulated with Infectimune in young and elderly ferrets
PLoS One. February 2026
PD-L1 is an intrinsic switch for natural killer cell-mediated, TRAIL-dependent antiviral function
Cell Rep. January 2026
Elicitation of Protective Immune Responses Against Influenza Virus Following Intranasal Delivery of Fluzone or Flublok Vaccines
Vaccines (Basel). January 2026
Contact Us
